Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Andrew Spencer, Sridurga Mithraprabhu, European Oncology & Haematology, 2016;12(2):96-102 DOI: https://doi.org/10.17925/EOH.2016.12.02.96 (Logo:...
Karen A Gelmon, European Oncology & Haematology, 2016;12(2):79-80 DOI: https://doi.org/10.17925/EOH.2016.12.02.79 (Logo:...
Nicolaus Kröger; European Oncology & Haematology, 2016;12(2):93-5 DOI: https://doi.org/10.17925/EOH.2016.12.02.93 (Logo:...
Patrick Wuchter, Kai Hübel, European Oncology & Haematology, 2016;12(2):87-92, https://doi.org/10.17925/EOH.2016.12.02.87 (Logo:...
Jean-Jacques Kiladjian, Yvonne Francis, Juliette Soret, European Oncology & Haematology, 2016;12(2):81-6 DOI: https://doi.org/10.17925/EOH.2016.12.02....
Howard L Kaufman, Oncology & Hematology Review, 2016;12(2):77-9 DOI: https://doi.org/10.17925/OHR.2016.12.02.77 (Logo:...
Shilpa Gupta, Neeraj Agarwal, Oncology & Hematology Review, 2016;12(2):82-8, https://doi.org/10.17925/OHR.2016.12.02.82 (Logo:...
Joleen M Hubbard, Axel Grothey, Oncology & Hematology Review, 2016;12(1):41-6 http://doi.org/10.17925/OHR.2016.12.01.41 Recently in Oncology &...
Andrew D Zelenetz, Oncology & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in Oncology &...
Oncology & Hematology Review, the peer-reviewed journal, has published a review highlighting recent data around rociletinib, an investigational...
European Oncology & Haematology Review, a peer-reviewed journal, has published a review highlighting the benefits of the Prosigna® (PAM50) Gene...
European Oncology & Haematology Review, the peer-reviewed journal, has published a review highlighting the Adverse Event Management in Anaplastic...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.